Cabot Financials

CBT

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE September

This page shows Cabot (CBT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 61/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Cabot has an operating margin of 16.7%, meaning the company retains $17 of operating profit per $100 of revenue. This strong profitability earns a score of 84/100, reflecting efficient cost management and pricing power. This is up from 15.4% the prior year.

Growth

Cabot's revenue declined 7% year-over-year, from $4.0B to $3.7B. This contraction results in a growth score of 8/100.

Leverage

Cabot carries a low D/E ratio of 0.55, meaning only $0.55 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 91/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Cabot's current ratio of 1.61 indicates adequate short-term liquidity, earning a score of 44/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Cabot has a free cash flow margin of 10.5%, earning a moderate score of 53/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Cabot earns a strong 21.3% return on equity (ROE), meaning it generates $21 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 85/100. This is down from 26.7% the prior year.

Altman Z-Score Safe

3.42

Cabot scores 3.42, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

6/9

Cabot passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.01x

For every $1 of reported earnings, Cabot generates $2.01 in operating cash flow ($665.0M OCF vs $331.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

8.2x

Cabot earns $8.2 in operating income for every $1 of interest expense ($621.0M vs $76.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Revenue

$3.7B

YoY-7.0%

5Y CAGR+7.3%

10Y CAGR+2.6%

Cabot generated $3.7B in revenue in fiscal year 2025. This represents a decrease of 7.0% from the prior year.

EBITDA

$775.0M

YoY+1.3%

5Y CAGR+34.1%

Cabot's EBITDA was $775.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 1.3% from the prior year.

Free Cash Flow

$391.0M

YoY-13.3%

5Y CAGR+17.2%

10Y CAGR+0.9%

Cabot generated $391.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 13.3% from the prior year.

Net Income

$331.0M

YoY-12.9%

Cabot reported $331.0M in net income in fiscal year 2025. This represents a decrease of 12.9% from the prior year.

EPS (Diluted)

$6.02

YoY-10.4%

Cabot earned $6.02 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 10.4% from the prior year.

Cash & Debt

$258.0M

YoY+15.7%

5Y CAGR+11.3%

10Y CAGR+12.9%

Cabot held $258.0M in cash against $856.0M in long-term debt as of fiscal year 2025.

Dividends Per Share

$1.76

YoY+6.0%

5Y CAGR+4.7%

10Y CAGR+7.2%

Cabot paid $1.76 per share in dividends in fiscal year 2025. This represents an increase of 6.0% from the prior year.

Shares Outstanding

53M

YoY-2.7%

5Y CAGR-1.3%

10Y CAGR-1.6%

Cabot had 53M shares outstanding in fiscal year 2025. This represents a decrease of 2.7% from the prior year.

Gross Margin

25.3%

YoY+1.3pp

5Y CAGR+6.2pp

10Y CAGR+4.9pp

Cabot's gross margin was 25.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 1.3 percentage points from the prior year.

Operating Margin

16.7%

YoY+1.4pp

5Y CAGR+15.9pp

10Y CAGR+27.8pp

Cabot's operating margin was 16.7% in fiscal year 2025, reflecting core business profitability. This is up 1.4 percentage points from the prior year.

Net Margin

8.9%

YoY-0.6pp

5Y CAGR+18.0pp

10Y CAGR+20.5pp

Cabot's net profit margin was 8.9% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.6 percentage points from the prior year.

Return on Equity

21.3%

YoY-5.3pp

Cabot's ROE was 21.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 5.3 percentage points from the prior year.

R&D Spending

$59.0M

YoY-6.3%

5Y CAGR+0.7%

10Y CAGR+0.2%

Cabot invested $59.0M in research and development in fiscal year 2025. This represents a decrease of 6.3% from the prior year.

Share Buybacks

$168.0M

YoY-2.3%

5Y CAGR+30.7%

10Y CAGR+5.2%

Cabot spent $168.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 2.3% from the prior year.

Capital Expenditures

$274.0M

YoY+13.7%

5Y CAGR+6.5%

10Y CAGR+6.9%

Cabot invested $274.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 13.7% from the prior year.

CBT Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$3.7B-7.0%	$4.0B+1.6%	$3.9B-9.0%	$4.3B+26.8%	$3.4B+30.4%	$2.6B
Cost of Revenue	$2.8B-8.6%	$3.0B-1.9%	$3.1B-10.0%	$3.4B+31.6%	$2.6B+23.5%	$2.1B
Gross Profit	$940.0M-2.1%	$960.0M+14.4%	$839.0M-5.2%	$885.0M+10.8%	$799.0M+59.8%	$500.0M
R&D Expenses	$59.0M-6.3%	$63.0M+10.5%	$57.0M+3.6%	$55.0M-1.8%	$56.0M-1.8%	$57.0M
SG&A Expenses	$260.0M-8.1%	$283.0M+11.9%	$253.0M-1.9%	$258.0M-10.7%	$289.0M-1.0%	$292.0M
Operating Income	$621.0M+1.1%	$614.0M+16.7%	$526.0M+35.2%	$389.0M-14.3%	$454.0M+2061.9%	$21.0M
Interest Expense	$76.0M-6.2%	$81.0M-10.0%	$90.0M+60.7%	$56.0M+14.3%	$49.0M-7.5%	$53.0M
Income Tax	$196.0M+76.6%	$111.0M+496.4%	-$28.0M-127.5%	$102.0M-17.1%	$123.0M-35.6%	$191.0M
Net Income	$331.0M-12.9%	$380.0M-14.6%	$445.0M+112.9%	$209.0M-16.4%	$250.0M+205.0%	-$238.0M
EPS (Diluted)	$6.02-10.4%	$6.72-13.1%	$7.73+113.5%	$3.62-16.6%	$4.34+203.1%	$-4.21

Metric	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23	Q3'23
Revenue	$849.0M-8.0%	$923.0M-1.4%	$936.0M-2.0%	$955.0M-6.0%	$1.0B-0.3%	$1.0B+6.4%	$958.0M-1.0%	$968.0M
Cost of Revenue	$638.0M-6.0%	$679.0M-2.3%	$695.0M-3.5%	$720.0M-5.3%	$760.0M-1.7%	$773.0M+4.5%	$740.0M-0.7%	$745.0M
Gross Profit	$211.0M-13.5%	$244.0M+1.2%	$241.0M+2.6%	$235.0M-8.2%	$256.0M+4.1%	$246.0M+12.8%	$218.0M-2.2%	$223.0M
R&D Expenses	$13.0M-13.3%	$15.0M0.0%	$15.0M+7.1%	$14.0M-12.5%	$16.0M+6.7%	$15.0M0.0%	$15.0M0.0%	$15.0M
SG&A Expenses	$69.0M+11.3%	$62.0M-3.1%	$64.0M-3.0%	$66.0M-2.9%	$68.0M-9.3%	$75.0M+11.9%	$67.0M+15.5%	$58.0M
Operating Income	$129.0M-22.8%	$167.0M+3.1%	$162.0M+4.5%	$155.0M-9.9%	$172.0M+10.3%	$156.0M+14.7%	$136.0M-9.3%	$150.0M
Interest Expense	$18.0M-5.3%	$19.0M0.0%	$19.0M+5.6%	$18.0M-5.3%	$19.0M-9.5%	$21.0M-4.5%	$22.0M-8.3%	$24.0M
Income Tax	$37.0M-14.0%	$43.0M-12.2%	$49.0M+19.5%	$41.0M+2.5%	$40.0M-14.9%	$47.0M+38.2%	$34.0M-17.1%	$41.0M
Net Income	$73.0M-27.7%	$101.0M+7.4%	$94.0M+1.1%	$93.0M-14.7%	$109.0M+29.8%	$84.0M+68.0%	$50.0M-39.0%	$82.0M
EPS (Diluted)	$1.37-26.3%	$1.86+10.1%	$1.69+1.2%	$1.67-13.9%	$1.94+30.2%	$1.49+69.3%	$0.88-38.5%	$1.43

CBT Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.8B+2.1%	$3.7B+3.7%	$3.6B+2.2%	$3.5B+6.6%	$3.3B+18.9%	$2.8B
Current Assets	$1.5B-4.1%	$1.6B-1.3%	$1.6B-10.7%	$1.8B+27.7%	$1.4B+45.7%	$978.0M
Cash & Equivalents	$258.0M+15.7%	$223.0M-6.3%	$238.0M+15.5%	$206.0M+22.6%	$168.0M+11.3%	$151.0M
Inventory	$504.0M-8.7%	$552.0M-5.6%	$585.0M-11.9%	$664.0M+27.0%	$523.0M+45.7%	$359.0M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$134.0M+0.8%	$133.0M-0.7%	$134.0M+3.9%	$129.0M-7.9%	$140.0M+4.5%	$134.0M
Total Liabilities	$2.3B-2.0%	$2.3B-1.2%	$2.3B-10.9%	$2.6B+11.4%	$2.4B+12.9%	$2.1B
Current Liabilities	$957.0M+24.0%	$772.0M-6.1%	$822.0M-25.6%	$1.1B-3.7%	$1.1B+116.8%	$529.0M
Long-Term Debt	$856.0M-21.3%	$1.1B-0.6%	$1.1B+0.5%	$1.1B+51.9%	$717.0M-34.5%	$1.1B
Total Equity	$1.6B+8.8%	$1.4B+12.7%	$1.3B+40.8%	$898.0M-5.2%	$947.0M+37.0%	$691.0M
Retained Earnings	$1.8B+5.8%	$1.7B+10.2%	$1.6B+22.6%	$1.3B+10.8%	$1.2B+17.2%	$989.0M

Metric	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23	Q3'23
Total Assets	$3.8B-2.1%	$3.8B+1.4%	$3.8B+3.9%	$3.6B-2.5%	$3.7B+3.9%	$3.6B-2.7%	$3.7B+2.5%	$3.6B
Current Assets	$1.5B-7.4%	$1.6B-1.9%	$1.6B+7.2%	$1.5B-6.8%	$1.6B0.0%	$1.6B-5.1%	$1.7B+4.1%	$1.6B
Cash & Equivalents	$230.0M-3.8%	$239.0M+12.2%	$213.0M+16.4%	$183.0M-17.9%	$223.0M+8.3%	$206.0M-15.6%	$244.0M+2.5%	$238.0M
Inventory	$503.0M-5.3%	$531.0M-1.8%	$541.0M+0.9%	$536.0M-2.9%	$552.0M+0.2%	$551.0M-10.7%	$617.0M+5.5%	$585.0M
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	$136.0M+2.3%	$133.0M+3.9%	$128.0M+0.8%	$127.0M-4.5%	$133.0M-2.9%	$137.0M-0.7%	$138.0M+3.0%	$134.0M
Total Liabilities	$2.2B-5.0%	$2.3B-2.6%	$2.4B+3.6%	$2.3B-1.5%	$2.3B+3.7%	$2.2B-5.8%	$2.4B+1.1%	$2.3B
Current Liabilities	$874.0M+18.1%	$740.0M-9.5%	$818.0M+9.5%	$747.0M-3.2%	$772.0M+7.5%	$718.0M-13.5%	$830.0M+1.0%	$822.0M
Long-Term Debt	$854.0M-22.7%	$1.1B+1.4%	$1.1B+0.1%	$1.1B+0.2%	$1.1B-0.1%	$1.1B-0.9%	$1.1B+0.4%	$1.1B
Total Equity	$1.6B+2.2%	$1.5B+8.0%	$1.4B+4.5%	$1.4B-4.1%	$1.4B+4.2%	$1.4B+2.9%	$1.3B+5.1%	$1.3B
Retained Earnings	$1.8B-0.5%	$1.8B+2.4%	$1.8B+1.7%	$1.8B+2.2%	$1.7B+6.3%	$1.6B+3.2%	$1.6B+0.5%	$1.6B

CBT Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$665.0M-3.9%	$692.0M+16.3%	$595.0M+495.0%	$100.0M-61.1%	$257.0M-31.8%	$377.0M
Capital Expenditures	$274.0M+13.7%	$241.0M-1.2%	$244.0M+15.6%	$211.0M+8.2%	$195.0M-2.5%	$200.0M
Free Cash Flow	$391.0M-13.3%	$451.0M+28.5%	$351.0M+416.2%	-$111.0M-279.0%	$62.0M-65.0%	$177.0M
Investing Cash Flow	-$298.0M-26.8%	-$235.0M-9.8%	-$214.0M-81.4%	-$118.0M+36.6%	-$186.0M+35.4%	-$288.0M
Financing Cash Flow	-$336.0M+19.0%	-$415.0M-3.0%	-$403.0M-377.9%	$145.0M+341.7%	-$60.0M+54.5%	-$132.0M
Dividends Paid	$96.0M+3.2%	$93.0M+5.7%	$88.0M+4.8%	$84.0M+5.0%	$80.0M0.0%	$80.0M
Share Buybacks	$168.0M-2.3%	$172.0M+75.5%	$98.0M+84.9%	$53.0M+1666.7%	$3.0M-93.2%	$44.0M

Metric	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23	Q3'23
Operating Cash Flow	$126.0M-49.4%	$249.0M+241.1%	$73.0M-41.1%	$124.0M-39.2%	$204.0M+15.9%	$176.0M+67.6%	$105.0M-23.9%	$138.0M
Capital Expenditures	$69.0M+13.1%	$61.0M-15.3%	$72.0M-6.5%	$77.0M-16.3%	$92.0M+114.0%	$43.0M-20.4%	$54.0M-30.8%	$78.0M
Free Cash Flow	$57.0M-69.7%	$188.0M+18700.0%	$1.0M-97.9%	$47.0M-58.0%	$112.0M-15.8%	$133.0M+160.8%	$51.0M-15.0%	$60.0M
Investing Cash Flow	-$69.0M-6.2%	-$65.0M+7.1%	-$70.0M+32.7%	-$104.0M-16.9%	-$89.0M-117.1%	-$41.0M+24.1%	-$54.0M+28.0%	-$75.0M
Financing Cash Flow	-$92.0M+49.7%	-$183.0M-1176.5%	$17.0M+170.8%	-$24.0M+73.0%	-$89.0M+46.4%	-$166.0M-472.4%	-$29.0M+9.4%	-$32.0M
Dividends Paid	$24.0M0.0%	$24.0M+4.3%	$23.0M-4.2%	$24.0M0.0%	$24.0M+4.3%	$23.0M+4.5%	$22.0M-4.3%	$23.0M
Share Buybacks	$52.0M+30.0%	$40.0M-14.9%	$47.0M+11.9%	$42.0M-36.4%	$66.0M+175.0%	$24.0M-27.3%	$33.0M-34.0%	$50.0M

CBT Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	25.3%+1.3pp	24.0%+2.7pp	21.3%+0.9pp	20.5%-3.0pp	23.4%+4.3pp	19.1%
Operating Margin	16.7%+1.4pp	15.4%+2.0pp	13.4%+4.4pp	9.0%-4.3pp	13.3%+12.5pp	0.8%
Net Margin	8.9%-0.6pp	9.5%-1.8pp	11.3%+6.5pp	4.8%-2.5pp	7.3%+16.4pp	-9.1%
Return on Equity	21.3%-5.3pp	26.7%-8.5pp	35.2%+11.9pp	23.3%-3.1pp	26.4%	N/A
Return on Assets	8.7%-1.5pp	10.2%-2.2pp	12.3%+6.4pp	5.9%-1.6pp	7.6%+16.1pp	-8.6%
Current Ratio	1.61-0.5	2.08+0.1	1.98+0.3	1.65+0.4	1.24-0.6	1.85
Debt-to-Equity	0.55-0.2	0.76-0.1	0.87-0.3	1.21+0.5	0.76-0.8	1.58
FCF Margin	10.5%-0.8pp	11.3%+2.4pp	8.9%+11.5pp	-2.6%-4.4pp	1.8%-4.9pp	6.8%

Metric	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23	Q3'23
Gross Margin	24.9%-1.6pp	26.4%+0.7pp	25.8%+1.1pp	24.6%-0.6pp	25.2%+1.1pp	24.1%+1.4pp	22.8%-0.3pp	23.0%
Operating Margin	15.2%-2.9pp	18.1%+0.8pp	17.3%+1.1pp	16.2%-0.7pp	16.9%+1.6pp	15.3%+1.1pp	14.2%-1.3pp	15.5%
Net Margin	8.6%-2.3pp	10.9%+0.9pp	10.0%+0.3pp	9.7%-1.0pp	10.7%+2.5pp	8.2%+3.0pp	5.2%-3.2pp	8.5%
Return on Equity	4.6%-1.9pp	6.6%-0.0pp	6.6%-0.2pp	6.8%-1.3pp	8.1%+2.0pp	6.1%+2.4pp	3.8%-3.5pp	7.2%
Return on Assets	1.9%-0.7pp	2.6%+0.2pp	2.5%-0.1pp	2.5%-0.5pp	3.0%+0.7pp	2.3%+1.0pp	1.4%-1.1pp	2.4%
Current Ratio	1.67-0.5	2.13+0.2	1.96-0.0	2.00-0.1	2.08-0.2	2.24+0.2	2.04+0.1	1.98
Debt-to-Equity	0.54-0.2	0.72-0.0	0.76-0.0	0.80+0.0	0.76-0.0	0.80-0.0	0.83-0.0	0.87
FCF Margin	6.7%-13.7pp	20.4%+20.3pp	0.1%-4.8pp	4.9%-10.3pp	15.3%+2.2pp	13.1%+7.7pp	5.3%-11.5pp	16.8%

Similar Companies

$4.0B

$5.1B

$3.1B

$3.7B

$5.9B

Frequently Asked Questions

What is Cabot's annual revenue?

Cabot (CBT) reported $3.7B in total revenue for fiscal year 2025. This represents a -7.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cabot's revenue growing?

Cabot (CBT) revenue declined by 7% year-over-year, from $4.0B to $3.7B in fiscal year 2025.

Is Cabot profitable?

Yes, Cabot (CBT) reported a net income of $331.0M in fiscal year 2025, with a net profit margin of 8.9%.

What is Cabot's earnings per share (EPS)?

Cabot (CBT) reported diluted earnings per share of $6.02 for fiscal year 2025. This represents a -10.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Cabot's EBITDA?

Cabot (CBT) had EBITDA of $775.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Cabot have?

As of fiscal year 2025, Cabot (CBT) had $258.0M in cash and equivalents against $856.0M in long-term debt.

What is Cabot's gross margin?

Cabot (CBT) had a gross margin of 25.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Cabot's operating margin?

Cabot (CBT) had an operating margin of 16.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cabot's net profit margin?

Cabot (CBT) had a net profit margin of 8.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Cabot pay dividends?

Yes, Cabot (CBT) paid $1.76 per share in dividends during fiscal year 2025.

What is Cabot's return on equity (ROE)?

Cabot (CBT) has a return on equity of 21.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cabot's free cash flow?

Cabot (CBT) generated $391.0M in free cash flow during fiscal year 2025. This represents a -13.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cabot's operating cash flow?

Cabot (CBT) generated $665.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cabot's total assets?

Cabot (CBT) had $3.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cabot's capital expenditures?

Cabot (CBT) invested $274.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Cabot spend on research and development?

Cabot (CBT) invested $59.0M in research and development during fiscal year 2025.

Does Cabot buy back shares?

Yes, Cabot (CBT) spent $168.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Cabot have outstanding?

Cabot (CBT) had 53M shares outstanding as of fiscal year 2025.

What is Cabot's current ratio?

Cabot (CBT) had a current ratio of 1.61 as of fiscal year 2025, which is generally considered healthy.

What is Cabot's debt-to-equity ratio?

Cabot (CBT) had a debt-to-equity ratio of 0.55 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cabot's return on assets (ROA)?

Cabot (CBT) had a return on assets of 8.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cabot's Altman Z-Score?

Cabot (CBT) has an Altman Z-Score of 3.42, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cabot's Piotroski F-Score?

Cabot (CBT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cabot's earnings high quality?

Cabot (CBT) has an earnings quality ratio of 2.01x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cabot cover its interest payments?

Cabot (CBT) has an interest coverage ratio of 8.2x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Cabot?

Cabot (CBT) scores 61 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.